Clinical Trials Browser

Terminated × Carcinoma, Non-Small-Cell Lung × Dasatinib × Clear all

NCT02954523 2024-07-05

Dasatinib and Osimertinib (AZD9291) in Advanced Non-Small Cell Lung Cancer With EGFR Mutations

Phase 1/2 Terminated

10 enrolled 15 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01514864 2023-12-19

Trial of Dasatinib in Patients With Advanced Cancers Harboring DDR2 Mutation or Inactivating B-RAF Mutation

Phase 2 Terminated

19 enrolled 18 charts

Carcinoma, Non-Small-Cell Lung

NCT00787267 2016-06-30

TOP0801

Phase 2 Terminated

37 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00564876 2015-02-23

TOP0706

Phase 2 Terminated

2 enrolled 4 charts

Carcinoma, Carcinoma, Non-Small-Cell Lung